SILVER SPRING, Md.—The U.S. Food and Drug Administration (FDA) is warning consumers not to purchase or use South Moon, Rebright or FivFivGo eye drops because of the potential risk of eye infection. According to the FDA, these are copycat eye drop products that consumers can easily mistake for Bausch + Lomb’s Lumify brand eye drops, an over-the-counter product approved for redness relief. South Moon, Rebright and FivFivGo eye drops are unapproved drugs and should not be available for sale in the U.S., the agency said. They claim to treat eye conditions such as glaucoma, which is treated with prescription drugs or surgery.

Patients who have signs or symptoms of an eye infection should talk to their health care provider or seek medical care immediately. The FDA recommends consumers properly discard these products.

As reported in VMAIL, the warning comes just months after an eye drop recall in which 26 products were pulled from store shelves due to safety concerns prompted by investigators finding unsanitary conditions at a manufacturing facility in India. That November recall was one of eight separate announcements related to eye drops last year.

The agency tested samples of South Moon and Rebright eye drops, purchased online. The South Moon eye drops were contaminated with Burkholderia cepacia complex, a group of bacteria that could result in an antibiotic-resistant infection. While Rebright testing was negative for contamination, the FDA recommends consumers not use this product.

FDA testing of the Rebright and South Moon eye drops also found that these copycat products lacked brimonidine tartrate, the active ingredient in Lumify. The FDA was unable to obtain FivFivGo samples. The origin of these products is currently unclear, and the FDA continues to investigate. South Moon is labeled as made by Shantou Cross-border Premium Products E-Commerce Co. Ltd. in China.

The FDA has not received any adverse event reports that specifically name the South Moon, Rebright or FivFivGo products. However, the agency has received reports related to possibly fake Lumify, including product quality concerns, eye irritation, pain and infection.

The agency recommends consumers only buy eye products from reputable retailers such as state-licensed pharmacies and beware of online retailers selling products with false claims.

Health care professionals and consumers should report adverse events or side effects related to the use of this product to FDA's MedWatch Safety Information and Adverse Event Reporting Program.